« Back to Record
Krop, I., Lee, S. C., de Boer, R., Petrakova, K., Vallentin, S., Perez, E. A., Piccart-Gebhart, M., Ellis, M. J. C., Winer, E. P., Gendreau, S., Derynck, M., Mayer, I. I., Lackner, M., Levy, G., Qiu, J., He, J., Schmid, P., Ganju, V., Dickler, M., Johnston, S., Morales, S., Yardley, D., Melichar, B., & Forero-Torres, A. (2016). Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet oncology, 17(6), 811-821. doi:10.1016/S1470-2045(16)00106-6
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/236159



